At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- Mix of remote tasks and in-person visits
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 21 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 50
- Started
- 2024-11-11
- Last checked
- 2026-07
Plain English Summary
What is this study?
- • Testing a new treatment for cancer
- • Clinical study - 50 participants
- • Digital monitoring in cancer survivors WHY
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with cancer
Where?
- • Bangor - Betsi Cadwaladr University Health board
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Digital monitoring in cancer survivors WHY? There is a large amount of evidence to suggest that addressing a cancer patients' quality of life and symptoms has a positive impact on their wellbeing and experience with care. Finding ways of accurately and timely measuring Patient Reported Outcomes (PROs), along with developing electronic and mobile health (eHealth and mHealth) solutions, is being increasingly recognized as one way to manage patients' quality of life and symptoms without increasing burden on time and resource-stretched National Health Services. WHAT? The main objective of this study is to assess the feasibility of administering routine self assessment through questionnaire called the Edmonton Symptom Assessment System (ESAS) via MS Forms associated with continuous wearing of a smart watch in cancer survivors. We also hope to identify predictors of attrition or dissatisfaction. WHO? Adult outpatients with controlled cancer undergoing surveillance (cancer survivors) WHERE? Participants will be identified through attendance in oncology outpatient clinics by the oncologist in charge. HOW? Participants will receive a smart watch and smart phone (or an App downloaded onto their own phone). The smart watch will record physical activity , sleep patterns and other data such as heart rate and participants are expected to wear the watch all the time for about 4 months. Participants will also attend the hospital for a research appointment at the start and the end of the research and complete questionnaires weekly throughout the study, delivered via MS forms. At the end of the study the patients will be invited to a focus group to discuss their experience. The study will last for 18 months; each participants' involvement will be for about 4 month.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓• Diagnosis of any solid cancer, at any stage
- ✓Completion of treatment (including surgery, radiotherapy, and any kind of cytotoxic systemic anticancer treatment...
- ✓Clinical, biochemical and radiological confirmation of controlled disease (no evidence of residual disease or...
- ✓Scheduled for either a therapeutic break (from cytotoxic systemic anticancer treatment), or having completed the...
- ✓Scheduled for active surveillance plan within oncology service or discharged to surgical or GP care following...
Who cannot take part
- ✗• Not in possession of a SIM card
- ✗No internet access through Wi-Fi or unwilling to use mobile data allowance on a daily basis
- ✗Unable to understand and follow the instructions autonomously
- ✗Uncontrolled severe other health conditions (I.e., cardiovascular, neurological, respiratory)
- ✗Lack of capacity
See the full criteria
Where Is This Study? (1 UK site)
Betsi Cadwaladr University Health board
Bangor LL57 2PW, United Kingdom